Insights

Professional
Practice
Industry
Region
Trending Topics
Location
Type

Sort by:

Firm News 6 results

Firm News | 5 min read | 08.20.26

Crowell & Moring Earns Top Honors in The Best Lawyers in America® 2027 Edition, with Two Attorneys Named Lawyer of the Year

Washington – August 20, 2026: The Best Lawyers in America® has recognized 57 of the firm's attorneys in its 2027 edition, a testament to the firm's deep bench of legal talent across practices and offices nationwide. In addition, 29 attorneys have been named to the Best Lawyers: Ones to Watch® list, recognizing outstanding attorneys earlier in their careers. 
...

Firm News | 7 min read | 06.04.26

Crowell & Moring Secures Top Rankings in Chambers USA 2026

Washington – June 4, 2026: Crowell & Moring earned 92 individual rankings for 81 attorneys, as well as 48 national and statewide practice area rankings, in the Chambers USA 2026 guide. The Chambers guide ranks the country’s top law firms and lawyers through in-depth research, client interviews, and feedback from attorneys at peer firms. 
...

Firm News | 3 min read | 08.20.25

The Best Lawyers in America 2026 Recognizes 44 Crowell & Moring Attorneys

Washington – August 20, 2025: The 2026 edition of The Best Lawyers in America® has recognized 44 Crowell & Moring lawyers as "Best Lawyers." 
...

Client Alerts 38 results

Client Alert | 9 min read | 10.21.26

Artificial Intelligence in Life Sciences: Reliability of AI-Generated Evidence in Drug Discovery and Development

The life sciences sector is uniquely vulnerable to the inherent risks of AI-generated evidence in drug development and discovery. This client alert focuses on five core challenges: hallucinations, skewed predictions from unrepresentative training data, the opacity of AI reasoning, input sensitivity that undermines reproducibility, and adversarial manipulation of training data. To address these risks, companies should use experimental validation and human oversight as the common legal and regulatory safety net. This entails among other measures auditing AI outputs, characterizing training data, and structural oversight. Companies also should prepare for evolving frameworks and guidance from the U.S. Food and Drug Administration (FDA) and the European Union (EU) that address use of AI in drug discovery and development .  
...

Client Alert | 4 min read | 10.14.26

Misleading Privacy Claims Can Trigger Massive Consumer-Protection Liability

At a glance: A New Mexico jury found Meta liable for nearly 44 million deceptive trade practice violations based on misleading privacy and platform-safety statements—showing that public-facing privacy claims can create significant consumer-protection exposure.
...

Client Alert | 7 min read | 10.01.26

SEC and FDA Formalize Information-Sharing Framework for Public Companies

On August 31, 2026, the U.S. Securities and Exchange Commission (SEC) and the U.S. Food and Drug Administration (FDA) signed a Memorandum of Understanding (MOU) establishing a formal framework for the two agencies to share non-public information concerning FDA-regulated products and the companies and individuals engaged in their manufacture, distribution, and sale. The MOU was signed by SEC Chairman Paul S. Atkins and Acting FDA Commissioner Kyle Diamantas. It takes immediate effect and runs for three years, subject to renewal, modification, or termination. In a press release, Chairman Atkins described FDA-related disclosures by public companies as having “a significant impact on our markets” and identified the FDA as “a valuable partner in our efforts to administer and enforce applicable disclosure requirements under the federal securities laws.” Acting Commissioner Diamantas framed the MOU as protecting “both the patients who rely on FDA-regulated products, and the public trust that drives health care innovation.”
...

Press Coverage 13 results

Press Coverage | 03.24.26

Broad New York Health Privacy Bill Could Be Revived After Veto

New York Law Journal

Press Coverage | 02.23.26

Notable Women in Law 2026

Crain's New York Business

Publications 7 results

Events 7 results

Event | 09.30.26, 9:00 AM EDT - 6:00 PM EDT

NewYorkBIO Innovation Summit

Crowell & Moring Partner Linda Malek, a member of the firm's Health Care Group, will be speaking at NewYorkBIO Innovation Summit, taking place September 30th in New York, NY.

Event | 10.08.25 - 10.10.25, 12:15 PM EDT - 4:45 PM EDT

AHLA Fraud and Compliance Forum

Crowell & Moring Partners Troy Barsky and Linda Malek, members of the firm's Health Care Group, will be speaking at the AHAL Fraud and Compliance Forum, taking place October 8-10th in Baltimore, MD.

Event | 08.04.25, 2:00 PM EDT - 3:00 PM EDT

Cultivating Research Integrity Summit

Crowell & Moring Partner Linda Malek, a member of the firm's Health Care and Privacy & Cybersecurity Groups, will be speaking at the Cultivating Research Integrity Summit, taking place on August 4, 2025 in Reading, Pennsylvania. Her presentation, "Artificial Intelligence and Research Integrity," will take place at 2:00 PM ET.

Webinars 5 results

Webinar | 10.28.26, 2:00 PM EDT - 3:00 PM EDT

AI Governance & Vendor Diligence for Providers

Health care providers are deploying AI at an unprecedented pace—from ambient documentation and AI-assisted diagnostics to remote patient monitoring—but rapid adoption brings significant legal, regulatory, and reputational risk. A growing patchwork of state AI laws, evolving federal frameworks, and emerging litigation are reshaping what providers must do to deploy these tools responsibly.

Webinar | 09.25.25

HOOPS 2025

We invite you to join the Health Care Group at Crowell for our Health Care Opportunities, Oversight, Policy, and Strategy (HOOPS) Summer Webinar Series. 

Webinar | 04.22.25, 11:00 AM EDT - 12:00 PM EDT

The Evolving AI Legal and Policy Landscape: Mid-2025 Update

With the launch of Crowell’s Evolving AI Legal and Policy Landscape tracker in 2023, we formed a team of attorneys and policy professionals tasked with monitoring and reporting on the most notable developments around AI. Join us for a roundtable discussion regarding worldwide legal and policy developments since July 2024 and what you need to know in 2025. Our presenters Jillian Ambrose, Sari Depreeuw, Kate Growley, and Linda Malek will explore...

Speaking Engagements 13 results

Blog Posts 9 results

Blog Post | 08.01.25

White House AI Action Plan Seeks to Establish “Dominance,” Boost Innovation, and Scrutinize Regulations

Crowell & Moring’s Government Contracts Legal Forum 

Podcasts 2 results

Podcast | 10.24.25

Payers, Providers, and Patients – Oh My!: AI in Healthcare – Key Policy Developments and State Laws

In this episode, hosts Payal Nanavati and Megan Beaver speak with Linda Malek and Matthew F. Ferraro about the latest federal and state developments in artificial intelligence (AI) policy affecting health care. The conversation covers the Trump administration’s AI action plan and Executive Orders on AI, new industry-specific and comprehensive state laws, and enforcement trends, with a focus on how these changes impact the health care industry.
...

Podcast | 06.14.24

Payers, Providers, and Patients – Oh My!: AI in Health Care Series, Part 1: AI Use in Clinical Research Institutions

In this episode, hosts Megan Beaver and Savanna Williams talk to Jason Johnson and Linda Malek about the evolving regulatory landscape related to artificial intelligence (AI) in health care. In particular, Jason and Linda discuss the use of AI by organizations engaged in clinical research including key issues and emerging themes in this field.
...